Sabra Health Care REIT Valuation
Is SBRA * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SBRA * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SBRA * (MX$245.71) is trading below our estimate of fair value (MX$402.95)
Significantly Below Fair Value: SBRA * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SBRA *?
Other financial metrics that can be useful for relative valuation.
What is SBRA *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$3.34b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 8.9x |
Enterprise Value/EBITDA | 14.4x |
PEG Ratio | 8.2x |
Price to Sales Ratio vs Peers
How does SBRA *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 13x | ||
EDUCA 18 Fideicomiso Irrevocable No. F/3277 en Banco Invex S. A. Institución de Banca Múltiple INVEX Grupo | 15.8x | 5.5% | Mex$64.8b |
FSITES 20 Fideicomiso Opsimex | 13.5x | n/a | Mex$88.1b |
FIBRAPL 14 FIBRA Prologis | 15.3x | 11.8% | Mex$87.8b |
TERRA 13 FIBRA Terrafina | 7.2x | 1.2% | Mex$32.7b |
SBRA * Sabra Health Care REIT | 5.2x | 3.7% | Mex$3.3b |
Price-To-Sales vs Peers: SBRA * is good value based on its Price-To-Sales Ratio (5.2x) compared to the peer average (12.7x).
Price to Earnings Ratio vs Industry
How does SBRA *'s PE Ratio compare vs other companies in the Global Health Care REITs Industry?
Price-To-Sales vs Industry: SBRA * is good value based on its Price-To-Sales Ratio (5.2x) compared to the Global Health Care REITs industry average (7x).
Price to Sales Ratio vs Fair Ratio
What is SBRA *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 5.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate SBRA *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.